Author

Chiara Arianna Accornero

Observed names: Chiara A Accornero, Chiara A. Accornero, Chiara Accornero

Institution: European Institute of Oncology

Observed institution: European Institute of Oncology

ORCID: 0000-0003-4226-164X

Observed ORCID: 0000-0003-4226-164X

OpenAlex ID: A5040311338

Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients

2022 · Federica Bellerba, Davide Serrano, et al. · Neoplasia · 39

Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort

2021 · Valentina Aristarco, Harriet Johansson, et al. · Nutrients · 10

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer

2024 · Aliana Guerrieri-Gonzaga, Davide Serrano, et al. · PLoS ONE · 6

Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial

2023 · Davide Serrano, Federica Bellerba, et al. · Biomedicines · 6

Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial

2021 · Aliana Guerrieri-Gonzaga, Davide Serrano, et al. · Contemporary Clinical Trials · 5

Combined pharmacologic and lifestyle intervention for breast cancer prevention: Results of the randomized phase II TOLERANT trial in high-risk women

2026 · Davide Serrano, Matteo Lazzeroni, et al. · European Journal of Cancer

Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project

2026 · Lois Riobó-Mayo, Lluis Salvador, et al. · International Journal of Epidemiology

Data from Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis

2026 · Irene Maria Briata, Stefano Spinaci, et al.

Supplementary Table 1 from Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis

2026 · Irene Maria Briata, Stefano Spinaci, et al.

Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis

2025 · Irene Maria Briata, Stefano Spinaci, et al. · Cancer Prevention Research

A phase II biomarker RCT in women at high risk for breast cancer: Low dose tamoxifen and lifestyle changes for breast cancer prevention (TOLERANT study).

2025 · Sara Gandini, Aliana Guerrieri-Gonzaga, et al. · Journal of Clinical Oncology

Works count: 11

Citation count: 66

H-index: 5

I10-index: 2